Novel compounds and methods for increasing klotho gene expression
OwnerJames Plante, William Ramage +1inventors
InventorsJames Plante, William Ramage, Michael Bishop
Life of this patent
Estimating the term…
Loading patent…
OwnerJames Plante, William Ramage +1inventors
InventorsJames Plante, William Ramage, Michael Bishop
Estimating the term…
Compositions and methods for the treatment and amelioration of arterial stiffness, hypertension, and/or arterial aging in a subject. In embodiments, the active agents of the compositions provide anti-aging treatments by causing arterial remodeling by decreasing collagen production and increasing elastin production in a subject. In certain embodiments, the active agents can be used to treat a subject having diabetes or a diabetes-related disease or condition, such as but not limited to, Type 1 diabetes mellitus (T1DM), Type 2 diabetes mellitus (T2DM), and hyperinsulenima (pre-diabetes). In certain embodiments, the active agents can be used to treat subjects having hypertension, aortic disease, cardiovascular disease, including heart failure (such as congestive heart failure), kidney disease, osteoporosis, Alzheimer's disease, infertility, and emphysema.
A method of treating at least one of artificial stiffness, hypertension in a subject in need of such therapy, comprising:
A method of treating arterial aging in a subject in need of such therapy, comprising:
A method of treating diabetes or a diabetes-related disease or condition in a subject in need of such therapy, comprising:
A method of (i) decreasing aortic expression of TGF-β1, TGF-β3, RUNX2, and ALP, (ii) increasing aortic expression of MMP2 and MMP9, (iii) increasing endothelial nitric oxide (NO) production, (iv) increasing kidney Klotho mRNA expression, (v) increasing serum Klotho protein levels, (vi) increasing arterial elastin levels, and (vii) decreasing arterial collagen production and arterial collagen levels in a mammalian subject, the method comprising:
Dependencies are inferred from the claim text.